Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CONCERTO: Laquinimod in RRMS
NCT01707992Phase 3Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Feb 2013
- Primary completion
- Apr 2015
- Modality
- Small Molecules
- Countries
- 30
01
Overview
A Phase 3 trial of laquinimod in relapsing-remitting multiple sclerosis (RRMS), sponsored by Teva Pharmaceutical Industries Ltd.. Started Feb 2013; status: completed.
02
Drugs
laquinimod
03
Conditions
relapsing-remitting multiple sclerosis (RRMS)
Beyond the preview
Go deeper on NCT01707992.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01707992.